Encyclopedia of Medical Immunology

2014 Edition
| Editors: Ian R. Mackay, Noel R. Rose, Dennis K. Ledford, Richard F. Lockey

Hypereosinophilic Syndromes

Reference work entry
DOI: https://doi.org/10.1007/978-1-4614-9194-1_91

Hypereosinophilic syndromes (HESs) is a different group of rare disorders defined by the presence of persistent peripheral blood eosinophilia (1,500 eosinophils/μl in blood), in the absence of any obvious reason of eosinophilia, such as parasitic or viral infections, allergic diseases, drug- or chemical-induced eosinophilia, hypoadrenalism, or nonhematological malignancies (Simon et al. 2010). HESs include platelet-derived growth factor receptor alpha (PDGFRA)–associated HES, lymphocytic variant HES (L-HES), familial hypereosinophilia, Churg-Strauss syndrome (CSS), organ-restricted eosinophilic disorders, and others (Simon et al. 2010). There are two categories for these difficult to diagnose disease: First, the cause might be due to increased production of cytokines-mediators that boost the differentiation and viability of eosinophils. These HES types are considered as “extrinsic eosinophilic disorders.” The second major group of hypereosinophilic diseases is due to mutation-mediated...

This is a preview of subscription content, log in to check access.

References

  1. Simon HU, Klion AD. Therapeutic approaches to patients with hypereosinophilic syndromes. Semin Hematol. 2012;49:160–70.PubMedCrossRefPubMedCentralGoogle Scholar
  2. Simon D, Simon HU. Eosinophilic disorders. J Allergy Clin Immunol. 2007;119:1291–300.PubMedCrossRefGoogle Scholar
  3. Simon HU, Rothenberg ME, Bochner BS, Weller PF, Wardlaw AJ, Wechsler ME, Rosenwasser LJ, Roufosse F, Gleich GJ, Klion AD. Refining the definition of hypereosinophilic syndrome. J Allergy Clin Immunol. 2010;126:45–9.PubMedCrossRefPubMedCentralGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  1. 1.Institute of PharmacologyUniversity of BernBernSwitzerland